Healthcare -
Biotechnology - NASDAQ - US
$ 15.5
-6.4 %
$ 2.25 B
Market Cap
-6.03
P/E
DNLI - SHARES OUTSTANDING
Shares Outstanding DNLI - Denali Therapeutics Inc.
137 M
LAST VALUE
6.32%
2 YEAR CAGR
8.20%
5 YEAR CAGR
0.00%
10 YEAR CAGR